The Impact of a Genomic Assay on Urologist Treatment Preference in Active Surveillance-Eligible Men
Thursday, March 9 at 12 PM Central Dr. Adam Murphy will summarize the results of a randomized controlled trial assessing the impact of a Genomic Assay on urologists and patients